Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 8Other hematologic neoplasm 6Lymphoid 5Classical hematology 4Plasma cell 3Sarcoma 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 17Lymphoma 13Leukemia, Myeloid, Acute 12Burkitt Lymphoma 12Lymphoma, Non-Hodgkin 11Lymphoma, Large B-Cell, Diffuse 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia 9Sarcoma, Myeloid 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6Blast Crisis 6Myelodysplastic Syndromes 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Lymphocytic, Chronic, B-Cell 5Recurrence 4Hodgkin Disease 4Congenital Abnormalities 4Neoplasms, Plasma Cell 3Myeloproliferative Disorders 3Multiple Myeloma 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Anemia, Refractory, with Excess of Blasts 3Anemia, Refractory 3Waldenstrom Macroglobulinemia 2

Interventions

Cyclophosphamide 19fludarabine phosphate 17Mycophenolic Acid 14Antilymphocyte Serum 13Peripheral Blood Stem Cell Transplantation 11Cyclosporine 11Tacrolimus 10Filgrastim 10Whole-Body Irradiation 9Radiotherapy 8Methotrexate 8Busulfan 8Methylprednisolone 7Cord Blood Stem Cell Transplantation 7Melphalan 6Etoposide 5sargramostim 3Sirolimus 3thymoglobulin 2Prednisone 2Polymerase Chain Reaction 2Ondansetron 2Itraconazole 2Imatinib Mesylate 2Granulocyte Colony-Stimulating Factor 2Flow Cytometry 2Early Intervention, Educational 2Amplified Fragment Length Polymorphism Analysis 2selinexor 1merphos 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Primary Myelofibrosis × Cytarabine × Sarcoma × Clear all
NCT00281879 2017-09-27

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

OHSU Knight Cancer Institute

Phase 2 Terminated
200 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡